Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female aged 18 to 65 years;~* A diagnosis of generalized anxiety disorder;~* Absence of current episode of major depression.~Exclusion Criteria:~* The presence or history of schizophrenia and other psychotic disorders;~* Hypertension;~* A current diagnosis of cancer, unless in remission for at least 5 years

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).